T. Rowe Price Associates
ONCS

T. Rowe Price Associates’s OncoSec Medical Incorporated ONCS Stock Holding History

T. Rowe Price Associates’s Portfolio ONCS Stock Details ONCS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
2021
Q1 		$54K Hold
2020
Q4 		$74K Sell
2020
Q3 		$58K Buy
2019
Q2 		– Sell
2019
Q1 		$32K Hold
2018
Q4 		$36K Sell
2018
Q3 		$215K Hold
2018
Q2 		$212K Buy
2018
Q1 		$182K Hold
2017
Q4 		$158K Buy